Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBiocon

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Axis Bank, Biocon; sell JSW Steel: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Axis Bank and Biocon and advises selling JSW Steel.

    • Buy Biocon, advises Rahul Shah

      Rahul Shah of Motilal Oswal is of the view that one can buy Biocon with a target of Rs 470.

    • Bull's Eye: Buy Biocon, Colgate, Zee Media, Ashok Leyland

      Shahina Mukadam, Independent Market Expert advises buying Zee Media Corporation with a target of Rs 24.

    • Bull's Eye: Buy UPL, Escorts, Suzlon, Biocon, Voltas, Dabur

      Rakesh Bansal of RK Global is of the view that one may buy Jindal Saw with a target of Rs 78.

    • Sell UPL Aug Futures, Biocon, Godrej Industries: IIFL

      Pritesh Mehta of IIFL recommends selling UPL August Futures, Biocon and Godrej Industries.

    • Like PTC India Fin, look at pharma, prefer Infosys: SBI Cap

      Mahantesh Sabarad of SBI Capital Securities likes PTC India Financial Services from the NBFC space and feels that Dr Reddy's Laboratories and Biocon can do substantially well from the pharma space.

    • Expect Biocon to hit Rs 495, says Amit Gupta

      Amit Gupta of ICICIdirect is of the view that Biocon may hit Rs 495.

    • Buy Biocon for short term, advises Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Biocon for short term.

    • Super Six trading stocks for short term gain

      Gaurav Bissa of LKP Securities advises buying Amara Raja Batteries with a target of Rs 980.

    • Hold Biocon with long term view: Vishal Malkan

      Vishal Malkan of malkansview.com advises holding Biocon with long term view.

    • Bull's Eye: Buy Biocon, Voltas, sell BoI, Crompton Greaves

      Sharmila Joshi, Market Expert advises buying Biocon with a target of Rs 478.

    • Buy Biocon 460 Call, advises VK Sharma

      VK Sharma of HDFC Securities recommends buying Biocon 460 call.

    • Buy Hindustan Unilever on declines: Mithil Pradhan

      Mithil Pradhan of Violet Arc Global Managers recommends buying Hindustan Unilever on declines.

    • Super Six: Top chart picks for July 16

      Kunal Bothra of LKP is of the view that one may buy Biocon with a target of Rs 508.

    • Buy Biocon, Ceat, Havells India: Gaurav Bissa

      Gaurav Bissa of LKP Securities recommends buying Biocon , Ceat and Havells India.

    • Buy Biocon, can test Rs 484 in 2-3 sessions: Manas Jaiswal

      Manas Jaiswal of manasjaiswal.com is of the view that one can buy Biocon as the stock can test Rs 484 in next 2-3 trading sessions.

    • Aurobindo Pharma, Biocon top picks: Naveen Kulkarni

      Naveen Kulkarni, co-head, research at Phillip Capital is of the view that Aurobindo Pharma and Biocon are the top picks from the pharma space.

    • Invest in Biocon, ICICI Bank with 12-18 months view: Joshi

      Sharmila Joshi of sharmilajoshi.com is of the view that one may invest in Biocon, Motherson Sumi Systems and ICICI Bank with a view of 12-18 months.

    • Buy Biocon, says Amit Gupta

      Amit Gupta of ICICIdirect is of the view that one may buy Biocon.

    • Biocon can hit Rs 479-480, says Gaurav Bissa

      Gaurav Bissa of LKP Securities is of the view that Biocon can catapult to Rs 479-480 in a very short span.

    • Prefer Biocon for long term: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can get positioned in Biocon on the long side.

    • Check out: Top 10 stocks in news today

      Here‘s a list of top 10 stocks that are in news due to their Q4 earnings and controversy.

    • Buy Biocon, says Sudarshan Sukhani

      According to Sudarshan Sukhani of s2analytics.com, one can buy Biocon and hold the stock for a few weeks.

    • See more upside for Biocon post Syngene listing: Phillipcap

      Biocon plans to list its research arm Syngene and on Wednesday filed prospectus with the market regulator Sebi. It aims to raise around Rs 600 crore.

    • Buy Biocon, says Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Biocon.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347